Dividend
-
-
-
-
-
-
-
AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
-
-
-
-
-
-
-
AMGEN announces CTO David Reese retirement and leadership changes
-
-
-
-
-
-
-
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
-
-
-
-
-
-
-
Amgen (AMGN) Declares $2.52 Quarterly Dividend; 3.2% Yield
-
-
-
-
-
-
-
Amgen (AMGN) Declares $2.38 Quarterly Dividend; 3.2% Yield
-
-
-
-
-
-
-
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
-
-
-
-
-
-
-
Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis
-
449,673 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

